Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca Read more
FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin 1 Read more
Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies Read more
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer Read more
AbbVie and Voyager Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies Read more
Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin Read more
Boehringer and Lilly’s CAROLINA cardiovascular outcome trial for Trajenta meets primary endpoint of non-inferiority compared to glimepiride Read more
Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials Read more
Novartis receives FDA approval for Egaten for the treatment of fascioliasis, a neglected tropical disease Read more